DTE

31.57

-0.63%↓

IBE

19.06

-0.47%↓

RWE

55

-2.34%↓

ELE

34.28

-1.01%↓

FORTUM.FI

20.53

-5.7%↓

DTE

31.57

-0.63%↓

IBE

19.06

-0.47%↓

RWE

55

-2.34%↓

ELE

34.28

-1.01%↓

FORTUM.FI

20.53

-5.7%↓

DTE

31.57

-0.63%↓

IBE

19.06

-0.47%↓

RWE

55

-2.34%↓

ELE

34.28

-1.01%↓

FORTUM.FI

20.53

-5.7%↓

DTE

31.57

-0.63%↓

IBE

19.06

-0.47%↓

RWE

55

-2.34%↓

ELE

34.28

-1.01%↓

FORTUM.FI

20.53

-5.7%↓

DTE

31.57

-0.63%↓

IBE

19.06

-0.47%↓

RWE

55

-2.34%↓

ELE

34.28

-1.01%↓

FORTUM.FI

20.53

-5.7%↓

Search

Wavestone

Geschlossen

BrancheBetriebsmittel

45.8 1.66

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

43.85

Max

46.45

Schlüsselkennzahlen

By Trading Economics

Einkommen

-18M

30M

Verkäufe

-28M

458M

KGV

Branchendurchschnitt

14.519

27.098

Dividendenrendite

0.98

Gewinnspanne

6.619

Angestellte

6,042

EBITDA

-22M

53M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+60.54% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.98%

2.99%

Nächstes Ergebnis

3. Juni 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-248M

1.1B

Vorheriger Eröffnungskurs

44.14

Vorheriger Schlusskurs

45.8

Nachrichtenstimmung

By Acuity

15%

85%

4 / 90 Ranking in Utilities

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Wavestone Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. März 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. März 2026, 22:55 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. März 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. März 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. März 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. März 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. März 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Global Equities Roundup: Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. März 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. März 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. März 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. März 2026, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. März 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. März 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. März 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. März 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. März 2026, 21:10 UTC

Wichtige Nachrichtenereignisse

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. März 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk
Ergebnisse
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Wavestone Prognose

Kursziel

By TipRanks

60.54% Vorteil

12-Monats-Prognose

Durchschnitt 72 EUR  60.54%

Hoch 72 EUR

Tief 72 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Wavestone – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

46.9 / N/AUnterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

4 / 90 Ranking in Betriebsmittel

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Wavestone

Wavestone SA provides consulting services in France and internationally. The company offers change and project management; compliance and resilience; core business software development; corporate finance, and HR, risk, and procurement; customer experience; cybersecurity; data and artificial intelligence; industry 4.0 and IoT; IT strategy and CTO advisory; operating model design and agility; SAP consulting; sourcing and services optimization; supply chain; and sustainability services. It serves the automotive and industry; banking; energy and utilities; government and international institutions; insurance; life sciences; retail, beauty, and luxury; and travel, transport, and logistics sectors. The company was formerly known as Solucom SA and changed its name to Wavestone SA in July 2016. Wavestone SA was incorporated in 1990 and is headquartered in Paris, France.
help-icon Live chat